Barbara Matuszczak, Manfred Windisch (Chemical compounds containing tocopherol and at least one additional pharmaceutically active substance.) WO 2005007650 A1
Barbara Matuszczak, Christa E. Müller (Preparation of triazoloquinoxalines as human A1, A2a, A2b and A3 adenosine receptor ligands.) WO 03/053973 A1
Ingo Ott, Brigitte Kirchner, Gottfried Heinisch, and Barbara Matuszczak* (Substituted Pyridazino[3,4-b][1,5]benzoxazepin-5(6H)ones as multidrug-resistance modulating agents) J. Med. Chem., 47, 4627-4630 (2004)
Christian Banekovich, Kurt Mereiter, and Barbara Matuszczak* (Pyrazolo[2',3':3,4][1,3]oxazino[5,6-b]quinoxaline, A Novel Tetra¬cyclic Ring System) Tetrahedron Lett. 44, 9161-9164 (2003)
Dietmar Rakowitz,* Barbara Matuszczak,* Luca Costantino, Andreas Krassnigg, Peter Hofbauer, and Stefan Gritsch (On the Prodrug-Potential of Novel Diphenylmethyleneaminooxycarboxylic Acid Derivatives) Eur. J. Pharm. Sci. 15, 11-20 (2002)
Gottfried Heinisch, Elisabeth Huber, and Barbara Matuszczak* (On the Synthesis of Novel 1,2-Diazine Containing Tricyclic Systems: Preparation of Tetra¬aza¬phenazines) Heterocycles 51, 1625-1630 (1999)
Gottfried Heinisch, Elisabeth Huber, Barbara Matuszczak*, and Kurt Mereiter (On the Synthesis of Novel 1,2-Diazine Containing Tricyclic Systems: Preparation of Di¬pyridazino¬diazepinones) Heterocycles 51, 1035-1050 (1999)
Barbara Matuszczak*, Elbieta Pekala, and Christa E. Müller (1-Substituted 4-[Chloropyrazolyl][1,2,4]triazolo[4,3-a]¬quinoxalines: Synthesis and Structure-Activity Relationships of a New Class of Benzodiazepine and Adenosine Receptor Ligands) Arch. Pharm. Pharm. Med. Chem. 331, 163-169 (1998)
Barbara Matuszczak* and Kurt Mereiter (Syntheses in the Series of Pyrazolyl-substituted Quinoxalines) Heterocycles 45, 2449-2462 (1997).
Gottfried Heinisch, Barbara Matuszczak,* and Kurt Mereiter (A Novel Type of 1,2-Diazine * 1,2-Diazole Ring Contraction) Heterocycles 38, 2081-2089 (1994).
